SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 85 filers reported holding SEELOS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590 | -88.2% | 3,209 | -23.1% | 0.00% | – |
| Q2 2023 | $4,986 | +83.9% | 4,172 | +6.3% | 0.00% | – |
| Q1 2023 | $2,711 | +90.2% | 3,923 | +87.0% | 0.00% | – |
| Q4 2022 | $1,425 | -52.5% | 2,098 | -36.5% | 0.00% | – |
| Q3 2022 | $3,000 | -96.9% | 3,304 | -97.7% | 0.00% | – |
| Q2 2022 | $98,000 | -76.4% | 144,819 | -70.9% | 0.00% | – |
| Q1 2022 | $416,000 | +127.3% | 496,967 | +342.1% | 0.00% | – |
| Q4 2021 | $183,000 | +1120.0% | 112,415 | +1682.7% | 0.00% | – |
| Q3 2021 | $15,000 | -93.5% | 6,306 | -92.8% | 0.00% | – |
| Q2 2021 | $232,000 | -36.6% | 87,822 | +19.9% | 0.00% | – |
| Q1 2021 | $366,000 | – | 73,265 | +1046542.9% | 0.00% | – |
| Q2 2020 | $0 | – | 7 | +600.0% | 0.00% | – |
| Q2 2019 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,500,000 | $4,075,000 | 1.71% |
| Connacht Asset Management LP | 498,925 | $813,000 | 0.79% |
| GENDELL JEFFREY L | 2,449,267 | $3,992,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 2,133,436 | $3,478,000 | 0.21% |
| Uniplan Investment Counsel, Inc. | 1,550,359 | $2,527,000 | 0.14% |
| Financial Advocates Investment Management | 24,673 | $1,994,000 | 0.13% |
| Connacht Asset Management LP | 72,300 | $118,000 | 0.12% |
| Woodline Partners LP | 4,047,231 | $6,597,000 | 0.09% |
| 1492 Capital Management LLC | 108,286 | $177,000 | 0.09% |
| Ikarian Capital, LLC | 244,171 | $398,000 | 0.06% |